PG-11144

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NamePG-11144
Drug Alias NameLSD1 inhibitors (Progen)lysine-specific demethylase 1 inhibitors (Cellgate)third-generation polyamine analogs (SLIL)LSD1 inhibitors (Cellgate)PG-11100 series +[19] 
ClassificationSmall molecules
Mechanisms of ActionLysine-specific histone demethylase 1 inhibitorsPolyamine metabolism modulatorsc-Jun N-terminal kinase inhibitors +[4] 
Targetsc-Jun N-terminal kinaseLysine-specific histone demethylase 1
Therapy Area/IndicationsNeoplasmsCryptosporidiosisMicrosporidiosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSLIL Biomedical Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEpi Pharmaceuticals IncSLIL Biomedical CorpCellgate +[4] 
Active IndicationsN/A
Inactive IndicationsNeoplasmsCryptosporidiosisMicrosporidiosis

Other Information

ATC CodeN/A
Related LinksN/A